Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/8/2019
SIETES contiene 92794 citas

 
 
 1 a 20 de 28 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
2.Enlace a cita original Cita con resumen
Pasina L, Zanotta D, Puricelli S, Bonoldi G. Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series. Eur J Clin Pharmacol 2016;72:641-3. [Ref.ID 100252]
3.Tiene citas relacionadas Cita con resumen
Libri V, Yandim C, Athanasopoulos S, Loyse N, Natisvli T, Law PP, Chan PK, Mohammad T, Mauri M, Tam KT, Leiper J, Piper S, Ramesh A, Parkinson MH, Huson L, Giunti P, Festenstein R. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study. Lancet 2014;384:504-13. [Ref.ID 97877]
4.Tiene citas relacionadas
Lynch DR, Fischbeck KH. Nicotinamide in Friedreich's ataxia: useful or not?. Lancet 2014;384:474-5. [Ref.ID 97876]
5. Cita con resumen
Anónimo. Perampanel (Fycompa) for epilepsy. Med Lett Drugs Ther 2014;56:9-10. [Ref.ID 97220]
6. Cita con resumen
Zaccara G, Perucca P, Gangemi PF. The adverse event profile of pregabalin across different disorders: a meta-analysis. Eur J Clin Pharmacol 2012;68:903-12. [Ref.ID 93103]
7.Enlace a cita original Cita con resumen
Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol 2011;72:381-93. [Ref.ID 90989]
8. Cita con resumen
Vitalone A, Menniti-Ippolito F, Moro PA, Firenzuoli F, Raschetti R, Mazzanti G. Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health. Eur J Clin Pharmacol 2011;67:215-24. [Ref.ID 90094]
9.Tiene citas relacionadas Cita con resumen
Marson AG, Tudur-Smith C, Williamson PR, Chadwick DW. Old versus new antiepileptic drugs: the SANAD study. Authors' reply. Lancet 2007;370:315-6. [Ref.ID 80666]
10.Tiene citas relacionadas
Hadzic N, Vara R, Raiman J, Mieli-Vergani G. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:315. [Ref.ID 80665]
11.Tiene citas relacionadas Cita con resumen
Shawcross D, Knighton S, Bernal W, Sizer E, Auzinger G. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:314-5. [Ref.ID 80664]
12.Tiene citas relacionadas Cita con resumen
Cross H, Ferrie C, Lascelles K, Livingston J, Mewasingh L. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:314. [Ref.ID 80663]
13.Tiene citas relacionadas
Panayiotopoulos CP. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:313-4. [Ref.ID 80662]
14.Tiene citas relacionadas Cita con resumen
Perucca E, Alexandre Jr V, Tomson T. Old versus new antiepileptic drugs: the SANAD study. Lancet 2007;370:313. [Ref.ID 80661]
15.Tiene citas relacionadas Cita con resumen
Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91. [Ref.ID 80570]
16.Tiene citas relacionadas Cita con resumen
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Schackley P, Shen J, Smith DF, Smith PEM, Smith CT, Vanoli A, Williamson PR, on behalf of the SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15. [Ref.ID 79591]
17.Tiene citas relacionadas Cita con resumen
French JA. First-choice drug for newly diagnosed epilepsy. Lancet 2007;369:970-1. [Ref.ID 79585]
18. Cita con resumen
Guerrini R. Epilepsy in children. Lancet 2006;367:499-524. [Ref.ID 76166]
19.
Cachat F, Tufro A. Phenytoin/isradipine interaction causing severe neurologic toxicity. Ann Pharmacother 2002;36:1399-402. [Ref.ID 63356]
20.
Woodruff BK, Wijdicks EFM, Marshall WF. Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med 2002;346:68-9. [Ref.ID 59889]
Seleccionar todas
 
 1 a 20 de 28 siguiente >>